Richard J Trauger Selected Research

17-ethynylandrostane-3,17-diol

1/2011	17α-ethynyl-5α-androstane-3α, 17β-diol treatment of MNU-induced mammary cancer in rats.
11/2009	HE3235 inhibits growth of castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard J Trauger Research Topics

Disease

2	Neoplasms (Cancer) 01/2011 - 11/2009
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 11/2009

Drug/Important Bio-Agent (IBA)

2	17-ethynylandrostane-3,17-diolIBA 01/2011 - 11/2009
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2011
1	Antineoplastic Agents (Antineoplastics)IBA 01/2011
1	Docetaxel (Taxotere)FDA Link 01/2011
1	Estrogens (Estrogen)FDA Link 01/2011
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2011
1	Tamoxifen FDA LinkGeneric 01/2011
1	androstaneIBA 01/2011
1	Androgen Receptors (Androgen Receptor)IBA 11/2009
1	Dihydrotestosterone (Androstanolone)IBA 11/2009
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2009
1	Testosterone (Sustanon)FDA Link 11/2009
1	AndrogensIBA 11/2009

Therapy/Procedure

1	Withholding Treatment 01/2011
1	Castration 11/2009
1	Therapeutics 11/2009